Patents for C12R 1 - Micro-organisms (92,025)
06/2005
06/08/2005CN1625596A Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold
06/08/2005CN1625562A Chimeric delta-endotoxin protein of CRY1EA and CRY1CA
06/08/2005CN1625345A Vital cell preparations containing lactic acid bacterium as the ative ingredient and food containing lactic acid
06/08/2005CN1624124A Amylase variants
06/08/2005CN1624115A Cell surface molecule mediating cell adhesion and signal transmission
06/08/2005CN1624114A Transgenic plant resistant to mycotoxins and methods
06/08/2005CN1205339C Method for producing L-glutaminc acid
06/07/2005US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods
06/07/2005US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer
06/07/2005US6903195 Obtaining a cell sample, lysing or permeabilizing the cells to antibodies, adding antibody to the cell sample, complexing antibody with CDN-1(a protein) and detecting the CDN protein
06/07/2005US6903071 Cartilage/bone inducing materials for reparation
06/07/2005US6902915 Comprise heat resistant proteolytic enzyme for conversion of N-acyl-DL-amino acid such as N-acetyl-DL-methionine into corespondinng D-methionine
06/07/2005US6902912 Fermentation via yeasts under aerobic conditions, then extraction
06/07/2005US6902906 Bacteria attenuated by a non-reverting mutation in each of the aroC, ompF and ompC genes, useful as vaccines
06/07/2005CA2270593C Subtilase variants and compositions
06/07/2005CA2222482C Non-virulent mycoplasma synoviae and vaccine thereof
06/07/2005CA2153135C Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains and compositions containing them
06/02/2005WO2005049808A1 Method for producing l-amino acid by fermentation
06/02/2005WO2005007845A3 Transgenic cells
06/02/2005US20050119165 Vascular endothelial growth factor dimers
06/02/2005US20050118695 Alpha-amylase mutants
06/02/2005US20050118610 Nucleotide sequences coding hydrolase for generating protein hydrolysates useful as flavour improving agents; food processing
06/02/2005US20050118192 Viral preparations, vectors, immunogens, and vaccines
06/02/2005US20050118176 Inhibiting binding of interleukin-4 (IL-4) to an IL-4 Receptor; suppressing an IL-4-dependent immune or inflammatory response in a mammal
06/02/2005US20050118159 recombinant DNA molecules that express homogenous lysostaphin and host cells transformed with these DNA molecules
06/02/2005US20050115897 Extraction and winterization of lipids from oilseed and microbial sources
06/02/2005DE4139840B4 Antigen-Zubereitung zum Nachweis von H. pylori Antigen preparation for the detection of H. pylori
06/02/2005CA2546678A1 Method for producing l-amino acid by fermentation
06/01/2005EP1536014A1 Process for producing glucose dehydrogenases
06/01/2005EP1535929A2 Megakaryocyte stimulating factors
06/01/2005EP1068302B1 Non-maltogenic exoamylases and their use in retarding retrogradation of starch
06/01/2005EP1066376B1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines
06/01/2005EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells
06/01/2005EP0804559B1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
06/01/2005EP0769059B1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
06/01/2005CN1204254C Protein DNA whose encoding makes colibacillus possess L-homoserine resistance and method for producing L-amino acid by using the same
06/01/2005CN1204245C Method for producing agricultural growth material
05/2005
05/31/2005US6900371 Pesticidal proteins
05/31/2005US6900293 Monoclonal antibodies directed against the microtubule-associated protein tau
05/31/2005US6900037 Method for producing amide compounds
05/31/2005US6899881 H. PYLORI FlbA POLYPEPTIDES, IMMUNOGENIC AND VACCINATING COMPOSITIONS COMPRISING H. PYLORI FlbA POLYPEPTIDES, AND COMPOSITIONS FOR DETECTION OF AN INFECTION COMPRISING H. PYLORI FlbA POLYPEPTIDES
05/26/2005US20050113273 Alkaline protease from bacillus gibsonii (DSM 14393) and washing and cleaning products comprising said alkaline protease
05/26/2005US20050112730 Nucleotide sequences which code for the opcA gene
05/26/2005US20050112112 Lactobacillus for treatment of eating disorders and pancreas defects; obesity; antidiabetic agents
05/25/2005EP1533382A1 Beta glucan-containing fat and oil compositions and novel microorganism capable of producing beta-glucan
05/25/2005EP1533380A2 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
05/25/2005EP1532165A2 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species
05/25/2005EP1531861A2 Mycoplasma gallisepticum formulation
05/25/2005EP1372670B1 Caloporoside derivatives, methods for the production thereof and their use
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1054993B1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
05/25/2005EP0871702B1 Cytokine designated lerk-7
05/25/2005CN1620511A Hyaluronan synthase genes and expression thereof
05/25/2005CN1620497A Bacteria with reduced genome
05/25/2005CN1620463A Pesticidal spinosyn derivatives
05/25/2005CN1620330A Extraction and winterization of lipids from oilseed and microbial sources
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1203184C Process for preparation of pseudomonic acid A antibiotic by microbiological method
05/25/2005CN1203170C Multi-enzyme product comprising glucoumylolytic, proteolytic and xylanolytic activities and process for preparing the same
05/24/2005US6897290 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H
05/24/2005US6897054 For controlling in vitro cell proliferation; genetic engineering
05/24/2005US6897048 Microorganisms and method for L-arginine production by fermentation
05/24/2005US6897041 For treating/preventing staphylococcal infections; transcription regulators; ion exchange resins; bacteriophages; genetic engineering/cloning
05/24/2005US6897030 CDNA sequence encoding porcine brain natriuretic peptide and related genes encoding canine and human peptides with natriuretic activity are disclosed. The gene is shown to make accessible the DNAs encoding analogous natriuretic peptides in
05/24/2005CA2166381C An improved method of preparing glyoxylic acid/aminomethylphosphonic acid mixtures using a microbial double-transformant
05/24/2005CA2100334C Process for preparing daunorubicin
05/24/2005CA2037607C Humanised antibodies
05/19/2005WO2005045053A1 Process for producing lactic acid bacerium culture containing bacteriocin and method of storing food using the same
05/19/2005WO2005045024A1 Promoter in the presence of organic acid and utilization thereof
05/19/2005WO2005045004A1 Controlling agent and controlling method for diesease damage on brassicaceous plants
05/19/2005WO2004015125A9 Process for preparing peptides with anti-hypertensive properties
05/19/2005US20050108787 Plant expression vector comprising nucleotide sequences coding acetohydroxyacid synthase (AHAS) for use as tool in generating imidazolinone herbicide resistant plants
05/19/2005US20050106702 Surfactant biocatalyst for remediation of recalcitrant organics and heavy metals
05/19/2005US20050106696 Enone reductase
05/19/2005US20050106674 Ephrin receptor binding protein for use as tool in treatment and prevention of cell proliferative and nervous system disorders
05/19/2005US20050106657 Using fungal propagation and fermentation to generate carotenoids for use as food and pharmaceutical supplements
05/19/2005US20050106601 Transgenic mouse whose somatic and germ cells express an Fkhsf transgene and mutants; immunomodulators
05/19/2005US20050106176 Vector reproduction using Dna polymerase; linking to chromosome; encoded as foreign gene; genetic engineering
05/19/2005US20050106133 Containing lactobacillus; storage stability
05/19/2005US20050106108 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
05/18/2005EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft
05/18/2005EP1530642A2 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions
05/18/2005EP1530626A1 Determination and/or control of reactor environmental conditions
05/18/2005EP1161530B1 Protein for blocking platelet adhesion
05/18/2005EP1034185B1 Pharmaceutical compositions containing the long pentraxin ptx3
05/18/2005EP0844888B1 Adenovirus vectors comprising a prostate specific antigen (psa) response element
05/18/2005EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase
05/18/2005EP0719342B1 Processes for producing polyhydroxybutyrate and related polyhydroxyalkanoates in the plastids of higher plants
05/18/2005EP0584348B1 Genetic vaccine for immunodeficiency viruses
05/18/2005CN1617934A Improved method of producing lycopene, preparation for obtaining lycopene, and application thereof
05/18/2005CN1617931A Esteralse with lipase activity
05/18/2005CN1617882A Method of isolation and purification of trypsin from pronase protease and use thereof
05/18/2005CN1616661A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors
05/18/2005CN1202244C Protein having aspartase activity and gene DNA coding for the same
05/18/2005CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment
05/18/2005CN1202126C Recombinant Newcastle disease virus capable of being used as embryo vaccine
05/18/2005CN1201818C Vaccine
05/17/2005US6893872 Pesticidal toxins
05/17/2005US6893861 By reacting a trifluoroacetoacetic acid derivative with a microorganism of the species Escherichia coli or cell- free extracts derived therefrom
05/17/2005US6893843 Nucleic acids